Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05678452

Comparative Study Between Safety and Effectiveness of High Versus Low Power HOLEP

Conditions: Benign Prostatic Hyperplasia

Sex: Male
Ages: 45 Years – N/A
Phase: NA
Enrollment: 200
Sponsor: Al-Azhar University

Location: Egypt

Summary

Holmium laser enucleation (HOLEP) has became a standard of treatment of large prostates that indicates surgery. HOLEP is widely used nowadays. Many settings are used but no optimal setting was world wide adopted. The aim of this trial is to assess the Low-power Holmium laser enucleation of the prostate (LP-HoLEP)and compare to high-power (HP-HoLEP) for enucleation efficiency pertaining to the advantages of lower cost and minimal postoperative dysuria, storage symptoms, and negative sexual impact.

Eligibility Criteria

Inclusion Criteria:large prostate indicated for surgical intervention.Exclusion Criteria:prostate cancerrecurrent adenomasassociated neurologic factors that may affect outcomes (e.g., neurogenic bladder)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05678452). StuddyBuddy aggregates publicly available trial information.